TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›RERE
RERE logo

RERE

ATRenew Inc.

Next earnings Aug 18, 2026 · consensus $0.91 EPS, $6.48B rev

Hold
$3.97
▼ -1.24%
$3.97▲ +16.36%
over 1Y
L $3.05H $6.20
Today-1.2%
1W+6.7%
1M-13.3%
3M-8.1%
YTD-25.1%
1Y+16.4%
OverviewFinancialsValuationQualityFilings
Rating
Hold
Quality
B+
Valuation
Undervalued
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy

Conservative balance sheet (liabilities/equity 0.50x).

Return on equity 8.4% · latest

The read

Middling fundamentals offset by an attractive price (~187% below fair value) — worth a look on the value angle.

ATRenew Inc. shows limited reported revenue, and 8.4% ROE.

Supporting the case: conservative balance sheet (liabilities/equity 0.50x); undemanding valuation (P/E 13.2).

Is RERE a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~3.97
  • Short call 4 @ ~0.39 est
debit $358max +$42max −$357BE 3.58

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income-$140M-$380M-$24.4M$3.97M$65.2M
Net income-$128M-$358M-$22.0M-$1.13M$48.1M
Diluted EPS—-$2.20-$0.14-$0.01$0.30
Net margin—————

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$706M
EV / EBITDA8.6
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)0.00
Earnings yield5.5%
FCF yield-9.1%

Quality & risk

ROIC (est.)8.4%
Free cash flow-$79.9M
Total debt$46.2M
Net cash$174M
Piotroski F-Score3/6

Capital returns

Buyback yield1.5%
Dividend yield (est.)—
Shareholder yield1.5%
Shares Δ YoY-0.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-102026-06-11open ↗6-KPeriod ending 2026-05-192026-05-19open ↗20-FPeriod ending 2025-12-312026-04-08open ↗4Period ending 2026-03-252026-03-26open ↗4Period ending 2026-03-252026-03-26open ↗4Period ending 2026-03-262026-03-26open ↗3Period ending 2026-03-182026-03-18open ↗3Period ending 2026-03-182026-03-18open ↗3Period ending 2026-03-182026-03-18open ↗3Period ending 2026-03-182026-03-18open ↗3Period ending 2026-03-182026-03-18open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueA
GrowthA+
ProfitabilityB-
Financial healthA-
MomentumF
  • ✓Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$11.40

Undervalued +187% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.30 × (8.5 + 1.5 × 22.0% growth) × 1.00 quality = 38.0× multiple. An estimate, not a price target.

3.0552-week6.20
Revenue
—
Net margin
—
ROE
8.4%
P/E
13.2

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$48.1M+4363.1%
Operating income$65.2M+1543.9%
Diluted EPS$0.30+3100.0%
Cash & equivalents$220M-18.5%
Total assets$853M+22.3%
Total liabilities$282M+47.7%
Stockholders' equity$571M+12.7%
L/E: 0.50x

Frequently asked

Is ATRenew Inc. (RERE) a buy?
RERE currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.50x).
What is RERE's fair value?
A Modified-Graham model based on RERE's SEC fundamentals estimates a fair value of about $11.40. It is an estimate from reported earnings, not a price target.
Is RERE overvalued or undervalued?
Against a Modified-Graham fair-value estimate, RERE currently appears undervalued relative to its SEC-grounded earnings power.
What is ATRenew Inc.'s quality score?
RERE scores 75.06538116280099/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001838957, latest 4 filed 2026-06-23) · EODHD · as of 7/5/2026, 1:47:52 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 9:47 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 1 sale

2026-06-18
Wang Jingbo
Director
Exercise15.0K
2026-06-10
Zhu Rui
Director
Exercise15.0K
2026-06-10
Zhu Rui
Director
Sell4.76K @ $4.00$19.0K
2026-03-26
Zhu Rui
Director
Exercise45.0K
2026-03-25
Chen Kerry Xuefeng
Chief Executive Officer
Exercise8.42M
2026-03-25
Wang Jingbo
Director
Exercise53.3K

Held by tracked funds

Form 13F · SEC · quarterly
Tiger GlobalChase Coleman9.83M sh$46.1M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Recent news

market news →
China's 618 shopping festival growth slows sharply as consumer spending malaise persistsBullish
cnbc.com· 2026-06-23
Sidoti Events, LLC's June Small-Cap Virtual ConferenceBullish
finance.yahoo.com· 2026-06-16
ATRenew And Two Insider-Favored Growth Stocks To WatchBullish
finance.yahoo.com· 2026-06-09
RERE: Diversification and a Dominant Market Position Enable ATRenew to Deliver Stellar Results Despite a Challenging Economic BackdropBullish
finance.yahoo.com· 2026-05-20
ATRenew anticipates Q2 2026 revenue of RMB 6.24B-RMB 6.34B while extending share repurchase programBullish
seekingalpha.com· 2026-05-19
ATRenew (RERE) Q1 2026 Earnings TranscriptBullish
finance.yahoo.com· 2026-05-19

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score75 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity8.4% vs 12.0%
P/E13.2 vs 26.2